References
- 1
Lambert R, Hainaut P.
Esophageal cancer: Cases and causes (Part I).
Endoscopy.
2007;
39
550-555
- 2
Takubo K, Arai T, Sawabe M. et al .
Structures of the normal esophagus and Barrett’s esophagus.
Esophagus.
2003;
1
37-47
- 3
Takubo K, Vieth M, Aryal G. et al .
Islands of squamous epithelium and their surrounding mucosa in columnar lined esophagus:
a pathognomonic feature of Barrett’s esophagus.
Hum Pathol.
2005;
36
269-274
- 4
Jankowski J A, Harrison R F, Parry I. et al .
Barrett’s metaplasia.
Lancet.
2000;
356
2079-2085
- 5
Paris Workshop on Columnar Metaplasia in the Esophagus and the Esophagogastric Junction,
Paris, France, December 11 - 12 2004.
Endoscopy.
2005;
37
879-920
- 6 Taniere P, Montesano R, Hainaut P.
The natural history of esophageal cancer. In: Shield PG (ed). Cancer risk assessement. London; Taylor and Francis 2005: 601-615
- 7
Taniere P, Martel-Plache G, Saurin J C. et al .
TP53 mutations, amplification of P63 and expression of cell cycle proteins in squamous
cell carcinoma of the oesophagus from a low incidence area in Western Europe.
Br J Cancer.
2001;
85
721-726
- 8
Sepehr A, Taniere P, Martel-Planche G. et al .
Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in
Iran.
Oncogene.
2001;
20
7368-7374
- 9
Mandard A M, Hainaut P, Hollstein M.
Genetic steps in the development of squamous cell carcinoma of the esophagus.
Mutat Res.
2000;
462
335-342
- 10
Mandard A M, Marnav J, Lebeau C. et al .
Expression of p53 in oesophageal squamous epithelium from surgical specimens resected
for squamous cell carcinoma of the oesophagus, with special reference to uninvolved
mucosa.
J Pathol.
1997;
18
153-157
- 11
Wang L D, Liu B, Zgen S.
Analysis of p53 mutational spectra of esophageal squamous cell carcinomas from Linzhou,
comparison with esophageal and other cancers from other areas [in Chinese].
Zhonghua Liu Xing Bing Xue Za Zhi.
2003;
24
202-205
- 12
Levrero M, De Laurenzi V, Costanzo A. et al .
The p53/p63/p73 family of transcription factors: overlapping and distinct functions.
J Cell Sci.
2000;
113
1661-1670
- 13
Daniely Y, Yao G, Dixon D. et al .
Critical role of p63 in the development of a normal esophageal and tracheobronchial
epithelium.
Am J Physiol Cell Physiol.
2004;
287
C171-C181
- 14
Morita M, Uramoto H, Ono K. et al .
Expression of deltaNp63 in squamous cell carcinoma of the esophagus.
Anticancer Res.
2005;
25
3533-3539
- 15
Hall P A, Woodman A C, Campbell S J. et al .
Expression of the p53 homologue p63alpha and DeltaNp63alpha in the neoplastic sequence
of Barrett’s oesophagus: correlation with morphology and p53 protein.
Gut.
2001;
49
618-623
- 16
Taniere P, Borghi-Scoazec G, Saurin J C. et al .
Cytokeratin expression in adenocarcinomas of the esophagogastric junction: a comparative
study of adenocarcinomas of the distal esophagus and of the proximal stomach.
Am J Surg Pathol.
2002;
26
1213-1221
- 17
Shimizu D, Vallbohmer D, Kuramochi H. et al .
Increasing cyclooxygenase-2 (cox-2) gene expression in the progression of Barrett’s
esophagus to adenocarcinoma correlates with that of Bcl-2.
Int J Cancer.
2006;
119
765-770
- 18
Inoue H, Rey J F, Lightdale C.
Lugol chromoendoscopy for esophageal squamous cell cancer.
Endoscopy.
2001;
33
75-79
- 19
Lundell L R, Dent J, Bennet J R. et al .
Endoscopic assessment of oesophagitis: clinical and functional correlates and further
validation of the Los Angeles classification.
Gut.
1999;
45
172-180
- 20
Labenz J, Jaspersen D, Kulig M. et al .
Risk factors for erosive esophagitis: a multivariate analysis based on the ProGERD
study initiative.
Am J Gastroenterol.
2004;
99
1652-1656
- 21
Noori P, Hou S M.
Mutational spectrum induced by acetaldehyde in the HPRT gene of human T lymphocytes
resembles that in the p53 gene of esophageal cancers.
Carcinogenesis.
2001;
22
1825-1830
- 22
Jacob J H, Riviere A, Mandard A M. et al .
Prevalence survey of precancerous lesions of the oesophagus in a high-risk population
for oesophageal cancer in France.
Eur J Cancer Prev.
1993;
2
53-59
- 23 Zhengzhou University International Symposium on Esophageal Cancer. 2005 August
27 - 30, Zhengzhou, China [unpublished data]
- 24
Wahrendorf J, Chang-Claude J C, Liang Q S. et al .
Precursor lesions of oesophageal cancer in young people in a high-risk population
in China.
Lancet.
1989;
2
1239-1241
- 25
Chang-Claude J C, Wahrendorf J, Liang Q S. et al .
An epidemiological study of precursor lesions of esophageal cancer among young persons
in a high-risk population in Huixian, China.
Cancer Res.
1990;
50
2268-2274
- 26
Dawsey S M, Lewin K J, Wang G Q. et al .
Squamous esophageal histology and subsequent risk of squamous cell carcinoma of the
esophagus. A prospective follow-up study from Linxian, China.
Cancer.
1994;
74
1686-1692
- 27
Wang G Q, Abnet C C, Shen Q. et al .
Histological precursors of oesophageal squamous cell carcinoma: results from a 13
year prospective follow up study in a high risk population.
Gut.
2005;
54
187-92
- 28
Wei W Q, Abnet C C, Lu N. et al .
Risk factors for oesophageal squamous dysplasia in adult inhabitants of a high risk
region of China.
Gut.
2005;
54
759-763
- 29
Lu X J, Chen Z F, Guo C L. et al .
Endoscopic survey of esophageal cancer in a high-risk area of China.
World J Gastroenterol.
2004;
10
2931-2935
- 30
Qiu S L, Yang G R.
Precursor lesions of esophageal cancer in high risk populations in Henan province,
China.
Cancer.
1988;
62
551-557
- 31
Yang G R, Qiu S L.
Endoscopic surveys in high-risk and low-risk populations for esophageal cancer in
China with special reference to precursors of esophageal cancer.
Endoscopy.
1987;
19
91-95
- 32
Munoz N, Crespi M, Grassi A. et al .
Precursor lesions of oesophageal cancer in high-risk populations in Iran and China.
Lancet.
1982;
1
876-879
- 33
Crespi M, Munoz N, Grassi A. et al .
Precursor lesions of oesophageal cancer in a low-risk population in China: comparison
with high-risk populations.
Int J Cancer.
1984;
34
599-602
- 34
Pourshams A, Saadatian-Elahi M, Nouraie M. et al .
Golestan cohort study of oesophageal cancer: feasibility and first results.
Br J Cancer.
2005;
92
176-181
- 35
Turkdogan M K, Akman N, Tuncer I.
Epidemiological aspects of endemic upper gastrointestinal cancers in eastern Turkey.
Hepatogastroenterology.
2005;
52
496-500
- 36
Jaskiewicz K, Venter F S, Marasas W F.
Cytopathology of the esophagus in Transkei.
J Natl Cancer Inst.
1987;
79
961-967
- 37
Liu C G, Zhang K, Jiang Y. et al .
Modulation of gene expression in precancerous rat esophagus by dietary zinc deficit
and replenishment.
Cancer Res.
2005;
65
7790-7799
- 38
Kamangar F, Strickland P T, Poursham A. et al .
High exposure to polycyclic aromatic hydrocarbons may contribute to high risk of esophageal
cancer in northeastern Iran.
Anticancer Res.
2005;
25
425-428
- 39
Sepehr A, Kamangar F, Fahimi S. et al .
Poor oral health as a risk factor for esophageal squamous dysplasia in northeastern
Iran.
Anticancer Res.
2005;
25
543-546
- 40
Si H X, Tsao S W, Poon C S. et al .
Viral load of HPV in esophageal squamous cell carcinoma.
Int J Cancer.
2003;
103
496-500
- 41
Crespi M, Munoz N, Grassi A.
Oesophageal lesions in northern Iran: a premalignant condition?.
Lancet.
1979;
2
217-221
- 42
Endo T, Awakawa T, Takahashi H. et al .
Classification of Barrett’s epithelium by magnifying endoscopy.
Gastrointest Endosc.
2002;
55
641-647
- 43
Ronkainen J, Aro P, Storzkrubb T. et al .
Prevalence of Barrett’s esophagus in the general population: an endoscopic study.
Gastroenterology.
2005;
129
1825-1831
- 44
Spechler S J.
Barrett’s esophagus: an overrated cancer risk factor.
Gastroenterology.
2000;
119
587-589
- 45
Reid B J, Blount P L, Rabinovitch P S.
Biomarkers in Barrett’s esophagus.
Gastrointest Endosc Clin N Am.
2003;
13
369-397
- 46
van der Burgh A, Dees J, Hop W CJ. et al .
Oesophageal cancer is an uncommon cause of death in patients with Barrett’s esophagus.
Gut.
1996;
39
5-8
R. Lambert, MD
Screening Group
International Agency for Research on Cancer
150 cours Albert Thomas
Lyon 69372
France
Fax: +33-4-72738518
Email: lambert@iarc.fr
